JRC-I-191
JRC-I-191 is an anti-HIV-1 agent. JRC-I-191 inhibits HIV-1 YU-2 entry into cells. JRC-I-191 does not inhibit infection of cells by amphotropic murine leukemia virus. JRC-I-191 can be used for the research of HIV-1 infection.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 1098209-30-3
- Formule: C17H23ClFN3O2
- Masse moléculaire:355.83
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Activité biologique
-
Chemical Information
- Pureté et documentation
- Références
-
Help & FAQs
Activité biologique
|
HIV-1 |
JRC-I-191 (Compound 3) inhibits HIV-1 YU-2 entry into Cf2Th-CD4/CCR5 cells with an IC50 of 54.4 μM, does not inhibit A-MLV infection[1].
JRC-I-191 binds to HIV-1 YU2 gp120 with a Kd of 0.76 μM[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 1098209-30-3
-
Masse moléculaire 355.83
-
Formule C17H23ClFN3O2
-
SMILES
O=C(C(NC1CC(C)(C)NC(C)(C1)C)=O)NC2=CC=C(C(F)=C2)Cl
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
JRC-I-191 Related Classifications
HY-182376 Related Classifications
Powered by Bioz